Oral misoprostol and uterine rupture in the first trimester of pregnancy: A case report

被引:18
作者
Kim, JO
Han, JY [1 ]
Choi, JS
Ahn, HK
Yang, JH
Kang, IS
Song, MJ
Nava-Ocampo, AA
机构
[1] Samsung Cheil Hosp, Korean Motherisk Program, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Womens Hlth Care Ctr, Seoul, South Korea
[3] Samsung Cheil Hosp, Dept Obstet & Gynaecol, Seoul 100380, South Korea
[4] Samsung Cheil Hosp, Dept Radiol, Seoul, South Korea
[5] Hosp Infantil Mexico Fed Gomez, Dept Clin Pharmacol, Mexico City, DF, Mexico
关键词
misoprostol; nonsteroidal abortifacient agents; oxytocics; uterine rupture;
D O I
10.1016/j.reprotox.2005.04.014
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We are reporting the case of a woman with 8 weeks of amenorrhea who orally received a single dose of misoprostol 400 mu g at midnight for ripening of cervix before uterine evacuation of an intrauterine gestational sac containing a single fetus (6.3 weeks of gestation) without cardiac activity. The patient had severe abdominal pain an hour later. Her blood pressure was 70/40 mmHg and her abdomen was slightly distended with direct and rebound tenderness. A transvaginal ultrasonography showed a 3-cm depth of a free fluid collection in the rectouterine pouch. Her hemoglobin and hematocrit levels were of 6.5 g/dL and 18.4%, respectively. A rupture of 1.5 cm at the left uterine horn with a protruding gestational sac was identified by laparoscopy. The gestational sac was removed and hernoperitoneal collection were successfully drained. The site of uterine rupture was primarily sutured and postoperative course was satisfactory. In summary, misoprostol administered in the first trimester of pregnancy may produce uterine rupture. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:575 / 577
页数:3
相关论文
共 20 条
[1]  
Akhan S. E., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P118
[2]   Uterine rupture during second-trimester abortion associated with misoprostol [J].
Berghahn, L ;
Christensen, D ;
Droste, S .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (05) :976-977
[3]  
CUNNINGHAM FG, 2001, WILLIAMS OBSTET, P619
[4]   Comparison between oral and vaginal administration of misoprostol on uterine contractility [J].
Danielsson, KG ;
Marions, L ;
Rodriguez, A ;
Spur, BW ;
Wong, PYK ;
Bygdeman, M .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (02) :275-280
[5]  
EDEN RD, 1986, OBSTET GYNECOL, V68, P671
[6]   DISPOSITION OF MISOPROSTOL AND ITS ACTIVE METABOLITE IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].
FOOTE, EF ;
LEE, DR ;
KARIM, A ;
KEANE, WF ;
HALSTENSON, CE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04) :384-389
[7]   Drug therapy: Misoprostol and pregnancy. [J].
Goldberg, AB ;
Greenberg, MB ;
Darney, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47
[8]  
Khabbaz A Y, 2001, J Matern Fetal Med, V10, P141, DOI 10.1080/714904310
[9]   Second and third medical termination of pregnancy with misoprostol without mifepristone [J].
Langer, B ;
Peter, C ;
Firtion, C ;
David, E ;
Haberstich, R .
FETAL DIAGNOSIS AND THERAPY, 2004, 19 (03) :266-270
[10]  
Letourneur B, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P371